CAITLIN SPARKS: Open Payments
NPI 1942955257 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 41 payments from 17 companies in 2025. Trend: 2023 $954 · 2024 $2,010 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $137 |
| Otsuka America Pharmaceutical, Inc. | 5 | $110 |
| Medtronic, Inc. | 1 | $98 |
| AKEBIA THERAPEUTICS INC | 3 | $87 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Novo Nordisk Inc | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Vifor Pharma, Inc. | 2 | $62 |
| Lilly USA, LLC | 2 | $46 |
Products named: TARPEYO, JARDIANCE, VENASEAL, JYNARQUE, Kerendia, Veltassa, Auryxia, Rybelsus.
Industry payments across AL — which companies pay providers there.
